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Abstract: The presence of more ATP-dependent potassium channels in females has been thought to play an important role in
protection against myocardial ischemia. In this study, we investigated whether there is a difference in the severity of ischemia and
reperfusion induced arrhythmias due to sex and, if there is, what the role of ATP-dependent potassium channel in this difference
is. The left anterior descending coronary artery in rats was ligated and arrhythmias were recorded in ECG during 6 min. of ischemia
and reperfusion. The duration of arrhythmias was shorter in females than in corresponding males. Glibenclamide was effective in
decreasing the duration of arrhythmias in males but not in females. This may be due to the presence of more ATP-dependent
potassium channels in females.
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Cinsiyetin Miyokardiyal ‹skemi - Reperfüzyon ile Uyar›lan Aritmiler Üzerine Etkisi ve ATP Ba¤›ml› Potasyum Kanal Blokaj›n›n Rolü
Özet: ATP ba¤›ml› potasyum kanal say›s›n›n diflilerde fazla oluflunun, miyokardiyal iskemiye karfl› korumada önemli bir rol oynad›¤›
düflünülmektedir. Bu çal›flmada, diflilerde iskemi ve reperfüzyon sonras› oluflan aritmi fliddetinde cinsiyete ba¤l› olarak farkl›l›k olup
olmad›¤› ve varsa bu farkl›l›kta ATP ba¤›ml› potasyum kanallar›n›n rolü araflt›r›ld›. S›çanlarda koroner ligasyon sol koroner arter
ba¤lanarak yap›ld› ve alt› dakikal›k iskemi ve reperfüzyon periyotlar› boyunca EKG kaydedildi. Reperfüzyon boyunca aritmi süreleri
difli cinsiyette erkek cinsiyete göre daha az bulundu. Glibenklamid aritmi sürelerini azaltmada erkeklerde etkili ancak diflilerde de¤ildi.
Bu sonuçlara göre, diflilerde ATP ba¤›ml› potasyum kanallar›n›n say›ca fazla olmas› aritmilere karfl› koruyucu olabilir.
Anahtar Sözcükler: Koroner Ligasyon, ‹skemi-Reperfüzyon, Aritmiler, Cinsiyet, Glibenklamid

Introduction
Glibenclamide is a sulfonylurea compound that blocks
the ATP-dependent potassium channel in ischemic cells.
Since extracellular potassium accumulation leads to the
nonuniform shortening of the action potential duration of
myocardial cells and contributes to the generation of
malignant arrhythmias, glibenclamide is expected to
protect against these arrhythmias. Likewise, several
investigations have suggested that the blockage of these
channels by glibenclamide, which selectively blocks the
ATP-dependent potassium channel, decreases the
incidence and duration of ventricular arrhythmias in
males (1,2) in vitro and (3-6) in vivo. Although these
findings indicate that glibenclamide is an antiarrhythmic
agent, it should be noted that some investigators have
described ATP-dependent potassium channel blockers as
proarrhythmic during the acute phase of myocardial
infarction (7,8).

Sex differences in susceptibility to cardiac disease have
been described extensively in the literature. The rate of
coronary heart disease in women before menopause is
much lower than that in men of the same age (9). The
major mechanism responsible for this protection is
thought to be the antiatherogenic action of female sex
hormones (10). Besides the chronic effect of estrogen on
lipid profiles, it has been shown that 17-β estradiol
reduces myocardial infarct size (11) and the incidence of
ischemia and reperfusion induced arrhythmias, (12,13)
and decreases myocardial damage and preserves left
ventricular function (14,15). One possible mechanism of
the cardioprotective effect of estrogen is suggested to be
enhanced nitric oxide (NO) production.
In recent years, it has been shown that the density of
the sarcolemmal ATP- dependent potassium channel was
higher in females than in males (16). In accordance with
studies suggesting that the activation of an ATP39
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dependent K+ channel is an important part of the
endogenenous cardioprotective effect that promotes
cellular survival under metabolic stress conditions (17), it
was reported in this in vitro study that the presence of
more cardiac ATP-dependent K+ channels contribute to
higher resistance against ischemia and reperfusion.
The main objectives of our study were to establish
whether there is a sex difference in ischemia and
reperfusion arrhythmias and to clarify the effect of ATPdependent K+ channel modulation by a channel blocker,
glibenclamide.

Materials and Methods
Animals
Male and female Sprague-Dawley rats weighing 220300 g and 7-8 months old were used. The animals were
fed commercial rat food pellets and allowed to drink tap
water ad libitum. All guiding principles declared by
Hacettepe University Ethics Committee, Turkey, for
animal care and use were followed.
Ischemia and reperfusion in anesthetized rats
The animals were anesthetized with thiopenthal
sodium (60 mg/kg). The trachea was cannulated for
artificial respiration. The left carotid artery was
cannulated for measuring the blood pressure transducer
(PowerLab, AD Instruments, United Kingdom) . The chest
was opened in the fourth intercostal space and the heart
was exposed (a loose loop of atraumatic silk was placed
around the left main coronary artery approximately 2
mm from its origin). Both ends of the ligature were led
out of the thoracic cavity through a flexible tubing. The
heart was replaced and artificial respiration was started
using an animal respirator (Ugo Basile Rodent Ventilator,
Italy) at 60 strokes/min. The animals were allowed to
stabilize for 5 min; then the loose loop of the coronary
artery ligature was tightened and fixed by a clamp on the
silk and thus regional myocardial ischemia was produced.
The 6 min of ischemia was followed by 6 min of
reperfusion produced by loosening the clamping on the
silk.
At the end of the experiment, in the surviving rats, the
heart was excised and perfused through the aorta with
solutions: first with 10 ml of NaCl and then with 2 ml of
ethanol for demarcation of the occluded and nonoccluded
myocardial regions. The nonperfused area that remained
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red was separated from the well-perfused area that
seemed white . The nonperfused myocardium was cut
with scissors and weighed. The percentage of this area to
the total weight of the ventricle was calculated. Bipolar
ECG and arterial blood pressure was recorded during the
6 min of coronary ligation and reperfusion and stored on
computer for later analysis.
Drug application
Glibenclamide was first dissolved in dimethylsulfoxide
and then mixed with ethanol in a 1/1 ratio. It was
intraperitoneally given in 5 mg /kg /100 µl, and 25 min
before coronary artery ligation. In the control groups,
instead of the glibenclamide, the same value of solvent
was applied.
Statistical analyses
The mean and standard errors were determined for
all parameters including the duration of arrhythmias,
blood pressure and heart rate. The duration of
arrhythmias, blood pressure and heart rate were
compared by analyses of variance (multivariate ANOVA
combined with the LSD post hoc test). The survival rate
and incidence of arrhythmias were compared by the chisquare test (Fisher’s exact test, 2 tailed).

Results
Changes in blood pressure and heart rate during
ischemia and reperfusion
Coronary ligation was not performed in rats having
decreased blood pressure below 70 mmHg before
ligation. In ECG, ST segment elevation or QRS changes
were observed in all animals following ligation. These
changes were not seen in unsuccessful ligation. Blood
pressure did not vary before coronary ligation but
decreased (P < 0.05) immediately after ligation in all
groups of animals. Blood pressure in the female control
group was significantly high with respect to that in the
male control group during coronary ligation (Table 1).
Following reperfusion, blood pressure gradually
increased. In female control group, blood pressure was
nonsignificantly higher than that in the corresponding
male group during reperfusion. However, blood pressure
after 3 and 5 min of reperfusion was significantly high in
female groups compared with that in the male group
treated with glibenclamide (P < 0.05), (Table 2).
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Table 1. Heart rate and mean arterial pressure during 6 min of coronary artery ligation in anaesthetized rats.
Heart Rate (beats/min)
Group

Blood Pressure (mmHg)

n
Basal

1 min

3 min

5 min

Basal

1 min

3 min

5 min

Male Control

9

336 ± 11

326 ± 15

314 ± 21

317 ± 16

179 ± 7

110 ± 13

113 ± 15

125 ± 11

Male Glibenclamide

10

338 ± 20

333 ± 22

333 ± 33

331 ± 19

185 ± 10

123 ± 15

125 ± 17

131 ± 14

Female Control

9

336 ± 10

372 ± 12

365 ± 13

360 ± 14

187 ±13

149 ± 8*

150 ± 10*

151 ± 12*

Female Glibenclamide

8

352 ± 27

363 ± 25

362 ± 13

352 ± 30

180 ± 10

141 ± 13

148 ± 16

130 ± 15

Data are mean ± SE. * P < 0.05, compared to corresponding male control value.
n: number of animals. Basal: Before coronary artery ligation and 1,3 and 5 min after coronary ligation.

Table 2. Heart rate and mean arterial pressure during 6 min of reperfusion.
Heart Rate (beats/min)
Group

Blood Pressure (mmHg)

n
1 min

3 min

5 min

1 min

3 min

5 min

Male Control

8

307 ± 21

321 ± 21

288 ± 23

121 ± 13

127 ± 11

142 ± 17

Male Glibenclamide

10

302 ± 10

323 ± 22

310 ± 21

108 ± 9

118±15

115 ± 15

Female Control

9

373 ± 28

348 ± 17

367 ± 20*b

144 ± 20

169 ± 10*c

161 ± 10*c

Female Glibenclamide

8

389 ± 36*a

325 ± 26

340 ± 24

93 ± 10

146 ± 16*c

158 ±12*c

Data are mean ± SE.
* P < 0.05; a: compared to male glibenclamide, b: compared to corresponding male control, c: compared to male glibenclamide
n: number of animals. 1, 3 and 5 min after reperfusion.

Heart rate was significantly higher in the female
glibenclamide group than that in the male glibenclamide
group after 1 min and also higher in the female control
group than in the male control group after 5 min of
reperfusion (P < 0.05), (Table 2).
Arrhythmias during ischemia and reperfusion in
anesthetized rats
The amount of myocardium supplied by the occluded
coronary artery did not differ among the groups; the
percentage of ischemic area to total ventricular weight
was 47 (n = 36 ). During the first 6 min after coronary
artery ligation, arrhythmias rarely occurred, and only one
of the male control animals died from ventricular
fibrillation (VF) before reperfusion (Table 4).

Arrhythmias usually appeared after 5-15 sec
following reperfusion. However they occured later in
male glibenclamide group compared to the control values
and the female glibenclamide group (P < 0.05). The
length of arrhythmic periods during reperfusion was
nonsignificantly lower in the female control group than
that in the corresponding male control group (Table 3).
The incidence of arrhythmias differed among the groups.
The incidence of VF was significantly lower in glibenclamide
treated males than that in the controls (P < 0.05). The
arrhythmia score was significantly lower in glibenclamide
treated males compared with the male control group.
Furthermore, the arrhythmia score in the female control
group was significantly lower than that in the corresponding
male control group (P < 0.05), (Table 4).
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Table 3. Duration of arrhythmias during reperfusion after 6 min of coronary ligation in surviving rats.
Duration of Arrhythmia Attack (s)
Group

n

Appearance of
arrhythmias (min)

Duration of
arrhythmias (min)

VF

VT

Other

Total

Bradycardia

Male Control

8

0.12 ± 0.02

4.40 ± 0.66

50 ± 24

53 ± 19

52 ± 16

155 ± 38

0

Male Glibenclamide

10

0.67 ± 0.25*a

4.67 ± 0.5

1 ± 1*a

10 ± 5

47±10

57 ± 8*a

0

Female Control

9

0.13 ± 0.05

2.77 ± 0.55 ψc

3 ± 2*a

44 ± 23

26 ± 6

72 ± 25*a

29 ± 29

Female Glibenclamide

8

0.16 ± 0.07*b

4.16 ± 0.60

3 ± 2*a

63 ± 28

35 ± 6

101 ± 32

0

Data are mean ± SE.
*P < 0.05; a: compared to male control, b: compared to male glibenclamide. ψP= 0.058; c: compared to male control.
Total= ventricular fibrillation (VF) + ventricular tachycardia (VT) + other types of arrhythmias including ventricular premature contraction (VPC),
ventricular gemini, AV nodal arrhythmia and salvo.
n: number of animals at the beginning of reperfusion.

Table 4. The incidence of arrhythmias during reperfusion after 6 min of coronary ligation in anesthetized rats.
Incidence of arrhythmia
Group

n
Survival

VF

VT

Other

Bradycardia

Arrhythmia
score

Male Control

8

8 / (88 %)

6 / (66%)

8 / (88%)

9 / (100%)

0

4.3 ± 0.4

Male Glibenclamide

10

10 / (100%)

1 / (10 %)*

4 / (40%)ψ

10 / (100%)

1 / (10%)

3 ± 0.2*

Female Control

9

9 / (100%)

2 / (22%)

9 / (100%)

9 / (100%)

0

3 ± 0.4*

Female Glibenclamide

8

8 / (100%)

2 / (25%)

7 / (87%)

8 / (100%)

0

3.5 ± 0.2

Data are mean ± SE. *P < 0.05, ψ P = 0.057: compared with male control.
VF: venricular fibrillation, VT: ventricular tachycardia, Other: arrhythmias include ventricular premature contraction (VPC), ventricular
nodal arrhythmia and salvo.
n: number of animals at the beginning of reperfusion.

Total arrhythmia was higher in females treated with
glibenclamide during coronary artery occlusion compared
to female control values (P < 0.05), (Table 5).
The duration of VF and total arrhythmia during the
reperfusion period was lower in the female control group
than that in the corresponding male group (P < 0.05). In
addition, the duration of VF and total arrhythmia was
significantly lower in the male group treated with
glibenclamide compared to the male control group.
Glibenclamide was effective in decreasing the duration of
arrhythmia in males but not in females. In contrast, it
nonsignificantly increased the duration of total
arrhythmias in females (Table 3).
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Discussion
Our present results clearly indicate that females have
greater resistance to reperfusion induced arrhythmias.
These findings are in agreement with previous reports by
Siegmund et al. (18). As in this study, the incidence of VF
and total ventricular arrhythmias decreased in female rats
with respect to males. This protective effect appears to be
mediated by estrogen. Previous studies demonstrated
that exogenous estrogen significantly attenuates ischemia
and reperfusion induced arrhythmias (11,13) and
reduces infarct size (14,15). One potential mechanism of
the cardioprotective effect of estrogen may be through
enhanced NO production. Since estrogen stimulates NO
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Table 5. Duration of arrhythmias during 6 min of coronary ligation in surviving rats.
Duration of Arrhythmia Attack(s)
Group

n
VF

VT

Other

Total

Bradycardia

Male Control

9

0

0

3±1

3±1

0

Male Glibenclamide

10

0

0

7±2

7±2

0

Female Control

9

0

0

2±1

3±1

0

Female Glibenclamide

8

1±1

2±1

7±2

10 ± 2 *

0

*P < 0.05: compared with female control values.
VF: venricular fibrillation, VT: ventricular tachycardia, Other: arrhythmias include ventricular premature contraction (VPC),
ventricular gemini, AV nodal arrhythmia and salvo.
n: number of animals at beginning of ligation.

production, females have a greater capacity to produce
NO than males (18). In another in vivo study, it was
proved that augmentation of endogenous NO release
induced by 17-β estradiol contributes to the alleviation of
irreversible ischemia reperfusion injury and reduces
infarct size (11). The cardioprotective effect of estrogen
has also been shown in males and this suggested that the
protection may depend on NO release from the coronary
endothelium, which increases coronary blood flow (13).
All of these studies suggest a protective role of
endogenous NO release in females during ischemia and
reperfusion. The low arrhythmia observed in females in
the present study might depend on this kind of protective
mechanism.
The presence of more cardiac ATP-dependent K
channels in females is another contribution to the higher
resistance of females to ischemia. Activation of this
channel is known as an endogenous cardioprotective
mechanism that attenuates ischemia (17). After ischemia,
the opening of the ATP-dependent K+ channel shortens
the myocardial action potential during repolarization. As
a result, the voltage dependent Ca++ influx into the
myocardial cell decreases along with ischemia. Since the
density of the ATP-dependent K+ channel is higher in
females, this protective mechanism works more
effectively in females than in male (16).

Several antiarrhythmic mechanisms for blockers of
the ATP-dependent K+ channel have been suggested.
Blockers inhibit K+ loss from jeopardized cells and prevent
nonuniform shortening of the action potential duration
during progressive myocardial ischemia (19). As in
previous in vitro (1) and in vivo studies (5), glibenclamide
decreases the development of electrical inhomogeneity
between ischemic and nonischemic myocardium and
suppreses the re-entrant pathways resulting in
antiarrhythmic, antifibrillatory action. Furthermore,
glibenclamide inhibits the shortening of the action
potential in ischemic cells during ischemia and preserves
the normal electrical stability of myocardial cells and so it
may prevent arrhythmias (9). Besides studies that
demonstrate the antiarrythmic effect of glibenclamide,
there are several studies that indicate a proarrhythmic
effect (7,8). In these studies, this effect is thought to
depend on the proischemic effect of glibenclamide. In
fact, glibenclamide increases Ca++ loading into the
myocardial cell and leads to further ischemia.
Furthermore, glibenclamide diminishes coronary blood
flow (8) and this also potentiates ischemia. The different
effect of glibenclamide may depend on 2 reason 1.
Decreased electrical inhomogeneity that provides an
antiarrhythmic effect; and 2. Increased ischemia that
potentiates arrhythmia (3).

The data presented here support previous reports
that indicate the antiarrhythmic effect of glibenclamide in
males (1,3,6,9 ). As in these studies, the incidence of VF
and total ventricular arrhythmias was significantly
decreased by glibenclamide in male rats.

We did not find any research indicating an
antiarrhythmic or proarrhythmic effect of glibenclamide
in females. In the present study, glibenclamide in females
did not cause an antiarrhythmic effect. In contrast, it
nonsignificantly increased arrhythmias during reperfusion

+
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and significantly increased the duration of total
arrhythmias during ligation compared to the male control
group. This may be explained by the different distribution
+
of the ATP-dependent K channel, which is higher in
females than in males (16). If the structure and
distribution of the ATP-dependent potassium channel
were the same in males and females, a similar outcome
might be expected in response to channel blockage. The
ineffectiveness of glibenclamide on the arrhythmia in
females may depend on its low affinity to the binding
sites on the channel protein. This suggestion is consistent
with the conclusion of El Reyani et al. (3) that different
agents from the sulfonylurea group have different effects
on arrhythmias induced by reperfusion.
++
In females, estrogen attenuates Ca overloading
during ischemia (20,21). In addition, since females have
+
more ATP-dependent K channels, cardiomyocytes
isolated from female hearts are more resistant to Ca++
overloading during reperfusion than male hearts (16).
More NO is released due to estrogen (11,22) and
endogenous NO release improves myocardial perfusion by
mediating the rapid recovery of coronary flow following
coronary ligation (23). In this study, the beneficial effects
of these kinds of advantages against ischemia may be
antagonized by pretreatment with glibenclamide, which
++
prolongs the action potential duration and activates Ca
influx; it also decreases the coronary blood flow. Because
males are devoid of this protection, glibenclamide might
induce more severe ischemia in females. Thus, the
proarrhythmic effect instead of anthiarrhythmia was
shown in the glybenclamide treated females in the
present study.

Ischemia and reperfusion cause myocardial
dysfunction (24). It has been demonstrated that chronic
estrogen administration resulted in an enhancement of
contractile function including cardiac output and aortic
flow during reperfusion (15, 25). Kim et al. (15)
suggested that the presevation of left ventricular function
during reperfusion was dependent on the antioxidant
properties of the estrogen. These studies support our
findings that the rapid recovery of blood pressure in
females during reperfusion may depend on alleviation of
myocardial dysfunction and preservation of ventricular
function by the effect of estrogen .
Vagal activation is more common in women than in
men during coronary artery occlusion; bradycardia and
decreased blood pressure are usually seen in females
44

rather than in males (26). In rats, the heart rate lowering
activity of vagal nerve stimulation is more profound in
females than in males (27). Furthermore, norepinephrine
(NE) release was found to be lower in females than in
males during ischemia due to greater α2 adrenoreceptor
mediated presynaptic inhibition in females (28). In
another study that was compatible with the findings
mentioned above, heart rate increased significantly in
males but decreased in females and blood pressure
showed a greater recovery in males than in females
during 6 min of coronary ligation (29). After the
vagotomy, this difference disappeared and blood pressure
and heart rate were found higher in females than in males
(29). Our results contradict this report, because, in
present study, blood pressure after ligation was higher in
females than that in males and heart rate was similar in
females and males. The reason of this discrepancy might
be the anesthesia influencing the parameters studied.
Thiopenthal sodium was used in our study, but
pentobarbital sodium was used in the comparable study
mentioned above.

Conclusion
It has been shown in this study that the incidence and
duration of ischemia and reperfusion induced arrhythmias
in females were lower than those in males. The different
response of glibenclamide in females might be attributed
to the different affinity of glibenclamide to the ATPdependent potassium channel or the different density of
the channel. Since glibenclamide was found not to affect
arrhythmias in females, further research is required to
clarify the opening or closing of the ATP-dependent
potassium channel or other factors involved in protection
against arrhythmias in females.
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